O'CONNELL JOSEPH P (Chief Medical Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/19/2020ACC: 0001209191-20-030766
Officer· Chief Medical Officer
Since Jun 2018
+78.00
Net shares
Net buyer
$936.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
78.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+39.00
Price / share
$24.00
Trade value
$936.00
% of position
2.0%
5/15/2020
1.95K→1.99K
Total
Net shares
+39.00
Net value
$936.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/15/2020 | A · Award | +39.00 | $24.00 | $936.00 | 2.0% | 1.95K | 1.99K |
| Total | +39.00 | $936.00 | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
39.00 shares
Shares
+39.00
Strike price
28.24
Held after
39.00
Exercisable
—
5/15/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock39.00 shares | 5/15/2020 | A · Award | +39.00 | 28.24 | — | 39.00 |